Novo Rapid Flex Pencmi 12
Novo Rapid Flex Pencmi 12
Novo Rapid Flex Pencmi 12
mellitus is a condition where your pancreas does not produce enough insulin to control your blood sugar (glucose) level. Extra insulin is therefore needed. There are two types of diabetes mellitus: Type 1 diabetes also called juvenile onset diabetes Type 2 diabetes also called maturity onset diabetes Patients with type 1 diabetes always require insulin to control their blood sugar levels. Some patients with type 2 diabetes may also require insulin after initial treatment with diet, exercise and tablets. NovoRapid lowers your blood sugar level after injection. When injected under your skin, NovoRapid has a faster onset of action than soluble human insulin. It takes effect within 10 to 20 minutes. Usually, the maximum effect will occur between 1-3 hours after injection and the effect may last for up to 5 hours. As with all insulins, the duration of action will vary according to the dose, injection site, blood flow, temperature and level of physical activity. Due to its shorter duration of action, NovoRapid has a lower risk of causing nocturnal hypoglycaemic episodes. FlexPen is a pre-filled dial-a-dose insulin pen able to deliver from 1 to 60 units of NovoRapid in increments of 1 unit. NovoRapid is not addictive. NovoRapid FlexPen is available only with a doctors prescription. Ask your doctor, diabetes education nurse or pharmacist if you have any questions about why NovoRapid FlexPen has been prescribed for you.
Things to be careful of ............. 5 Side effects................................. 5 After using NovoRapid FlexPen .................................................... 6 Product Description ................. 6 Further information ................. 7 Instructions For Use................. 8 This leaflet answers some common questions about NovoRapid FlexPen . It does not contain all the available information. It does not take the place of talking to your doctor, diabetes education nurse or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using NovoRapid FlexPen against the benefits they expect it will have for you. If you have any concerns about using this medicine, ask your doctor, diabetes education nurse or pharmacist. Keep this leaflet with the medicine. You may need to read it again.
Page 1 of 10
Tell your doctor if you have or have had any medical conditions, especially the following: kidney problems liver problems adrenal, pituitary or thyroid gland problems
in passing urine caused by an enlarged prostate non-selective beta-blocking agents - used for the treatment of certain heart conditions and high blood pressure angiotensin converting enzyme (ACE) inhibitors - used for the treatment of certain heart conditions, high blood pressure or elevated protein/albumin in the urine salicylates e.g. aspirin - used to relieve pain and lower fever anabolic steroids - used to promote growth glucocorticoids (except when applied locally) - used to treat inflammatory conditions oral contraceptives (the pill) used for birth control thiazides, frusemide or ethacrynic acid - used for the treatment of high blood pressure or fluid retention (oedema) thyroid hormones - used for the treatment of malfunction of the thyroid gland sympathomimetics - used for the treatment of asthma sulphonamides - used to treat bacterial infections specific medicines
nicotinic acid - used for the treatment of high cholesterol levels in the blood asparaginase - used to treat leukaemia and lymph gland tumours quinine - used for the prevention of malaria and the relief of muscle cramps quinidine - used for the control of heart problems growth hormone - used to treat growth disorders
Tell your doctor if you are pregnant or plan to become pregnant. NovoRapid can be used in pregnancy. Pregnancy may make managing your diabetes more difficult. Insulin needs usually decrease during the first three months of pregnancy and increase during the last six months. Your doctor can discuss with you the risks and benefits involved. Tell your doctor if you are breastfeeding or plan to breast-feed. Your doctor or pharmacist can discuss with you the risks and benefits involved. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema). Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who are treated with thiazolidinediones in combination with insulin may develop heart failure. If you have not told your doctor about any of the above, tell them before you use NovoRapid.
Tell your doctor about any other medicines that you are taking. This is very important. Your doctor will advise you if it is all right to keep taking them or if you should stop taking them. Your doctor and pharmacist have more information on medicines to be careful with or avoid while using this medicine.
Or other including:
danazol - used to treat endometriosis, menorrhagia, fibrocystic breast disease and hereditary angioedema oxymetholone - used to treat certain blood disorders octreotide - used to treat gastrointestinal endocrine tumours and enlargement of parts of the body (e.g. hands, feet, head) caused by abnormal growth hormone levels lanreotide used to treat enlargement of parts of the body (e.g. hands, feet, head) caused by abnormal hormone levels diazoxide - used for the treatment of high blood pressure
Page 2 of 10
When to use it
NovoRapid should normally be used immediately (up to 10 minutes) before your meal or carbohydrate snack. When necessary NovoRapid may be used immediately after the meal.
How to use it
Inject NovoRapid under the skin (subcutaneous injection) as shown to you by your doctor or diabetes education nurse. NovoRapid may be injected into the abdomen, thighs, buttocks or upper arms. Remember to change your injection site regularly as shown to you by your doctor or diabetes education nurse. In an emergency, the insulin contained within NovoRapid is suitable for FlexPen intravenous administration, under medical supervision only. For emergency use, the insulin must first be withdrawn from FlexPen into a syringe. Discard your FlexPen after emergency use. If you use NovoRapid and another type of insulin, you must use a separate insulin delivery system for each type of insulin. your NovoRapid
The first symptoms of mild to moderate hypos can come on suddenly. They may include:
dose
If you forget your insulin dose, test your blood sugar level as soon as possible. If you are not sure what to do, talk to your doctor, diabetes education nurse or pharmacist. Do not use a double dose of your insulin. If it is almost time for your next dose, skip the dose you missed and use your next dose when you are meant to. Otherwise, use it as soon as you remember dont forget to eat some carbohydrate within 10 minutes of your injection and then go back to using it as you would normally. Your blood sugar levels may become high (hyperglycaemia) if you:
Always carry some sugary food or fruit juice with you. If you experience any of these symptoms of a hypo, immediately eat some sugary food or have a sugary drink e.g. lollies, biscuits or fruit juice, and measure your blood sugar level. Tell your relatives, friends, close workmates or carers that you have diabetes. It is important that they recognise the signs and symptoms of a hypo. Make sure they know to give you some sugary food or fruit juice for mild to moderate symptoms of a hypo. If you lose consciousness, make sure they know:
Checking FlexPen
Check your NovoRapid FlexPen before each preparation and injection. Make sure you are using the correct type of insulin. Do not use this medicine if it is thickened, coloured, or has solid bits in it. Read the instructions printed at the end of this leaflet carefully in
Keep using your insulin even if you feel well. It helps to control your condition, but does not cure it. Tell your doctor if you often have hypos (low blood sugar levels). Your doctor may need to adjust your insulin dose. Always carry some sugary food or fruit juice with you. If you experience any of the symptoms of a hypo, immediately eat some sugary food or have a drink e.g. lollies, biscuits or fruit juice. Tell your doctor if you have trouble recognising the symptoms of hypos. Under certain conditions, the early warning signs of hypos can be different or less obvious. Your doctor may need to adjust your insulin dose. Make sure that you tell every doctor, dentist, pharmacist or other health care professional who is treating you that you have diabetes and are using insulin. Tell your doctor, diabetes education nurse or pharmacist if you are travelling. Ask them for a letter explaining why you are taking injecting devices with you. Each country you visit will need to see this letter, so you should take several copies. You may need to inject your insulin and eat your meals at different times because of time differences in and between countries. You may not be able to get the same type of insulin in the country you are visiting. Your doctor, diabetes education nurse or pharmacist can provide you with some helpful information.
Do not use this medicine to treat any other complaints unless your doctor tells you to. Do not give your medicine to anyone else, even if they have the same condition as you. Do not share needles or pens.
Things to be careful of
Be careful driving or operating machinery until you know how the insulin affects you. If your blood sugar is low or high your concentration and ability to react might be affected, and therefore also your ability to drive or operate a machine. Bear in mind that you could endanger yourself or others. Please ask your doctor whether you can drive a car: if you have frequent hypos if you find it hard to recognise hypoglycaemia
drowsy feeling flushed face thirst, loss of appetite fruity odour on the breath blurred vision passing larger amounts of urine than usual getting up at night more often than usual to pass urine high levels of glucose and acetone in the urine Symptoms of severe hyperglycaemia include:
heavy breathing fast pulse nausea, vomiting dehydration loss of consciousness Severe hyperglycaemia can lead to unconsciousness and in extreme cases death if untreated. Discuss any worries you may have about this with your doctor, diabetes education nurse or pharmacist.
Tell your doctor if you drink alcohol. Alcohol may mask the symptoms of hypos. If you drink alcohol, your need for insulin may change as your blood sugar level may either rise or fall. Careful monitoring is recommended. Tell your doctor if you are ill. Illness, especially with nausea and vomiting, may cause your insulin needs to change. Even if you are not eating, you still require insulin. You and your doctor should design an insulin plan for those times when you are sick. Tell your doctor if you are exercising more than usual. Exercise may lower your need for this medicine. Exercise may also speed up the effect of a dose of it, especially if the exercise involves the area of the injection site (e.g. the leg should not be used for injection prior to jogging or running). Tell your doctor if your diet changes. Changes in diet may cause your insulin needs to change.
Page 4 of 10
Side effects
Tell your doctor, diabetes education nurse or pharmacist as soon as possible if you do not feel well while you are using NovoRapid FlexPen. This medicine helps most people for whom it is prescribed, but it may have unwanted side effects in a few people. All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects. Do not be alarmed by the following lists of side effects. You may not experience any of them. Ask your doctor, diabetes education nurse or pharmacist to answer any questions you may have. The most common side effect when using insulin is low blood sugar levels (a hypo). Tell your doctor if you notice any of the following and they worry you: hypos (mild to moderate) pain, redness, hives, bruising, swelling or itching at the injection site. Usually these symptoms disappear within a few weeks during continued use. If you have serious or continuing reactions, you may need to stop using NovoRapid and use another insulin. a depression or thickening of the skin around the injection site (lipodystrophy) when you first start your insulin treatment you may get visual problems or swollen hands and feet This list includes the more common side effects of your medicine. They are usually mild and short-lived. If any of the following happen, tell your doctor immediately or go to Accident and Emergency at your nearest hospital: More severe symptoms of low blood sugar levels, including:
NovoRapid FlexPen NovoRapidFlexPencmi12.doc
disorientation seizures, fits or convulsions loss of consciousness. If a severe hypo is not treated, it can cause brain damage and death. Tell your doctor immediately or go to Accident and Emergency at your nearest hospital if you notice any of the following: skin rashes over a large part of the body shortness of breath, wheezing swelling of the face, lips or tongue fast pulse sweating This list includes very serious side effects. You may need urgent medical attention or hospitalisation. These side effects are very rare. Tell your doctor if you notice anything that is making you feel unwell. Other side effects not listed above may also occur in some people. Ask your doctor, diabetes education nurse or pharmacist to answer any questions you have.
by keeping the pen cap on when not in use. Never use NovoRapid FlexPen after the expiry date printed on the label and carton. Never use NovoRapid FlexPen if the solution is not clear and colourless. Keep out of the reach of children.
Disposal
Dispose of used needles safely into a yellow plastic sharps container. If your doctor tells you to stop using this medicine or the expiry date has passed, ask your pharmacist what to do with any medicine that is left over.
Product Description
What it looks like
NovoRapid is a clear, colourless solution for subcutaneous injection. NovoRapid FlexPen is a 3mL prefilled glass cartridge contained in a dial-a-dose insulin pen.
Ingredients
NovoRapid contains insulin aspart (rys) 100 units per mL (100 U/mL) as the active ingredient. The abbreviation rys indicates the method of genetic engineering used to manufacture the insulin aspart. NovoRapid also contains the following inactive ingredients: glycerol, phenol, meta-cresol, zinc chloride, sodium chloride, dibasic sodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
Sponsor
NovoRapid FlexPen is supplied in Australia by: Novo Nordisk Pharmaceuticals Pty. Ltd. Level 3 21 Solent Circuit Baulkham Hills NSW 2153 Australia
Page 5 of 10
NovoRapid FlexPen is supplied in New Zealand by: Novo Nordisk Pharmaceuticals Ltd. 58 Richard Pearse Drive Airport Oaks Mangere New Zealand NovoRapid, FlexPen, NovoFine, NovoTwist, Protaphane, Levemir and NovoCare are registered trademarks of Novo Nordisk A/S. This leaflet was prepared on 20 January 2012. Australian Registration Number: AUST R 133445 2012
Further information
For further information call the NovoCare Customer Care Centre on 1800 668 626 (Australia) or 0800 733 737 (NZ). www.novonordisk.com.au www.novonordisk.co.nz You can also get more information about diabetes and insulin from Diabetes Australia and Diabetes New Zealand: freecall helpline 1300 136 588 (Australia) www.diabetesaustralia.com.au www.diabetes.org.nz
Page 6 of 10
NovoRapid FlexPen
Insulin aspart (rys)
Maintenance
Your FlexPen is designed to work accurately and safely. It must be handled with care. If it is dropped or crushed, there is a risk of damage and leakage of insulin. You can clean the exterior of your FlexPen by wiping it with an alcohol swab. Do not soak it, wash or lubricate it as this may damage the pen. Do not refill your FlexPen.
B Remove the paper tab from a NovoFine or NovoTwist disposable needle. If using a NovoFine needle screw the needle onto your FlexPen so that it is straight and secure. If using a NovoTwist needle, twist the needle onto your FlexPen until a "click" is heard.
NovoRapid FlexPen NovoRapidFlexPencmi12.doc Page 7 of 10
C Pull off the big outer needle cap and keep it for later.
Always use a new needle for each injection. Be careful not to bend or damage the needle before use. To reduce the risk of needlestick injury, never put the inner needle cap back on once you have removed it from the needle.
F
NovoRapid FlexPen NovoRapidFlexPencmi12.doc Page 8 of 10
Hold your FlexPen with the needle pointing upwards and tap the cartridge gently with your finger a few times to make any air bubbles collect at the top of the cartridge.
G Keeping the needle upwards, press the push-button all the way in. The dose selector returns to 0. A drop of insulin should appear at the needle tip. If not, change the needle and repeat the procedure no more than six times. If a drop of insulin still does not appear, your FlexPen has failed to prime, and you must use a new one.
Page 9 of 10
J Keep the push-button fully depressed after the injection until the needle has been withdrawn from the skin. The needle must remain under the skin for at least six seconds. This will ensure that the full dose has been injected.
K Guide the needle into the big outer needle cap without touching the big outer needle cap, as shown. When the needle is covered, carefully push the big outer needle cap completely on and then remove the needle by unscrewing it (for NovoFine needles) or with a twist (for NovoTwist needles). Dispose of it carefully and put the pen cap back on.
Always remove the needle after each injection and store your FlexPen without the needle attached. Otherwise, the insulin may leak out, which can cause inaccurate dosing. Health care professionals, relatives and other carers should follow general precautionary measures for removal and disposal of needles, to eliminate the risk of needlestick injury. Dispose of your used FlexPen carefully, without the needle attached. Do not share your FlexPen or needles with anyone else.
Page 10 of 10